Kobo Biotech (BOM:531541) Treasury Stock: ₹ Mil (As of Jun. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:531541 Kobo Biotech Ltd BOM:531541
13 GF Score
Price ₹4.29
View Full Analysis

What is Kobo Biotech Treasury Stock?

Kobo Biotech BOM:531541 -1.83% 13 Treasury Stock is ₹ Mil as of Jun. 2024. GuruFocus rates BOM:531541 with a GF Score™ of 13/100.

Treasury stock is the portion of shares that a company keeps in their own treasury. Kobo Biotech's treasury stock for the quarter that ended in Jun. 2024 was ₹ Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

Kobo Biotech Treasury Stock Historical Data

* Premium members only.

The historical data trend for Kobo Biotech's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kobo Biotech Treasury Stock Chart

Kobo Biotech Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Treasury Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Kobo Biotech Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Treasury Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.00 - 0.00 -
BOM:531541
13GF Score
Kobo Biotech Ltd BOM:531541
Treasury Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kobo Biotech Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Frequently Asked Questions Learn more about Treasury Stock →
What does a Treasury Stock of ₹ Mil mean?
Kobo Biotech (BOM:531541) has a Treasury Stock of ₹ Mil as of Jun. 2024. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for Kobo Biotech and its competitors.
Is Kobo Biotech's Treasury Stock too high?
Kobo Biotech's current Treasury Stock is ₹ Mil. Overall, Kobo Biotech has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Kobo Biotech's Treasury Stock compare to ZTS?
Kobo Biotech's Treasury Stock of ₹ Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Treasury Stock for a Drug Manufacturers company?
A good Treasury Stock depends on the Drug Manufacturers industry context. However, Treasury Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Treasury Stock mean?
A high Treasury Stock can signal that a stock is expensive relative to its fundamentals. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for Kobo Biotech and its competitors. Kobo Biotech's current Treasury Stock is ₹ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kobo Biotech stock overvalued right now?
Kobo Biotech (BOM:531541) has a current Treasury Stock of ₹ Mil. The current Treasury Stock is ₹ Mil. Kobo Biotech's overall GF Score™ is 13/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Treasury Stock calculated?
Treasury Stock is calculated from a company's financial statements. For Kobo Biotech (BOM:531541), the current Treasury Stock is ₹ Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kobo Biotech Business Description

Address Saki Vihar Road, Unit 104, HYDE Park, Opposite Ansa Industrial Estate, Andheri (East), Mumbai, MH, IND, 400 072
Kobo Biotech Ltd is a pharmaceutical company. Its business comprises the manufacturing and sale of APIs (Active Pharmaceutical Ingredients) based on fermentation technology and Intermediates to pharmaceutical companies.
13GF Score

Get the complete analysis for BOM:531541

Treasury Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹4.29
Price